Medicare Enrolled
Dr. Ernesto Bustinza Linares, M.D.
Hematology · Deland, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bustinza Linares from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bustinza Linares? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bustinza Linares
Dr. Ernesto Bustinza Linares is a hematology in Deland, FL, with 18 years in practice. Based on federal Medicare data, Dr. Bustinza Linares performed 104,931 Medicare services across 3,039 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bustinza Linares received a total of $18,795 from 85 pharmaceutical and/or device companies across 989 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bustinza Linares is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 43% volume in FL$ $18,795 industry payments
Medicare Practice Summary
Medicare Utilization ↗104,931
Medicare services
Top 43% in FL for hematology
3,039
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,830 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 58,650 | $0 | $4 |
| Iron sucrose injection (Venofer) | 12,800 | $0 | $5 |
| Anti-nausea injection (aprepitant) | 8,190 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 6,420 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 4,090 | $6 | $23 |
| Immune globulin infusion (Gammagard) | 2,502 | $36 | $108 |
| Dexamethasone injection (steroid) | 2,058 | $0 | $3 |
| Complete blood count (CBC) with differential | 1,922 | $8 | $29 |
| Blood draw (venipuncture) | 1,718 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,000 | $1 | $28 |
| Office visit, established patient (30-39 min) | 790 | $96 | $339 |
| Drug injection, under skin or into muscle | 673 | $10 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 612 | $0 | $9 |
| Office visit, established patient (20-29 min) | 415 | $66 | $239 |
| Injection of additional new drug or substance into vein | 345 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 339 | $95 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 337 | $48 | $189 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 262 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 250 | $22 | $84 |
| Injection, carboplatin, 50 mg | 183 | $2 | $41 |
| Injection, diphenhydramine hcl, up to 50 mg | 130 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 123 | $15 | $56 |
| Prothrombin time test (blood clotting) | 107 | $4 | $15 |
| Administration of chemotherapy into vein, each additional hour | 104 | $21 | $79 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 91 | $16 | $59 |
| Infusion into a vein for hydration, 31-60 minutes | 90 | $24 | $156 |
| Infusion into a vein for hydration, each additional hour | 85 | $10 | $42 |
| Infusion, normal saline solution , 1000 cc | 84 | $2 | $7 |
| Automated urinalysis | 78 | $2 | $8 |
| Administration of additional new drug or substance into vein, 1 hour or less | 73 | $49 | $178 |
| Injection of drug or substance into vein | 60 | $28 | $156 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 53 | $1 | $7 |
| New patient office visit, complex (60-74 min) | 49 | $169 | $585 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 46 | $3 | $11 |
| Initial hospital admission, high complexity | 44 | $137 | $556 |
| Administration of additional new drug or substance into vein using push technique | 43 | $42 | $170 |
| Office visit, established patient, complex (40-54 min) | 32 | $140 | $474 |
| New patient office visit (45-59 min) | 31 | $121 | $453 |
| Drawing of blood for a medical problem | 27 | $73 | $277 |
| Hospital follow-up visit, high complexity | 25 | $94 | $285 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
59.3% high complexity
35.6% medium
5.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,795
Total received (2018-2024)
Avg $2,685/year across 7 years
Top 26% in FL for hematology
85
Companies
989
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,656 (88.6%)
Other
Charitable contributions, space rental, and other categories
$1,904 (10.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$235 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,879
2023$3,778
2022$2,697
2021$2,589
2020$1,857
2019$2,482
2018$2,512
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$3,455
Janssen Biotech, Inc.
$1,064
Celgene Corporation
$1,036
E.R. Squibb & Sons, L.L.C.
$964
Amgen Inc.
$902
PFIZER INC.
$768
GENZYME CORPORATION
$618
Genentech USA, Inc.
$548
AstraZeneca Pharmaceuticals LP
$529
Gilead Sciences, Inc.
$474
Seagen Inc.
$470
Merck Sharp & Dohme LLC
$432
Merck Sharp & Dohme Corporation
$428
Daiichi Sankyo Inc.
$427
Lilly USA, LLC
$421
Astellas Pharma US Inc
$396
Takeda Pharmaceuticals U.S.A., Inc.
$362
Pharmacyclics LLC, An AbbVie Company
$303
Bayer HealthCare Pharmaceuticals Inc.
$294
NOVARTIS PHARMACEUTICALS CORPORATION
$285
Kite Pharma, Inc.
$204
TerSera Therapeutics LLC
$199
Foundation Medicine, Inc.
$180
Ipsen Biopharmaceuticals, Inc
$165
Pharmacyclics LLC, an AbbVie Company
$155
ABBVIE INC.
$155
Incyte Corporation
$153
Regeneron Healthcare Solutions, Inc.
$150
EISAI INC.
$147
BeiGene USA, Inc.
$147
Alexion Pharmaceuticals, Inc.
$146
Seattle Genetics, Inc.
$146
Boehringer Ingelheim Pharmaceuticals, Inc.
$128
Puma Biotechnology, Inc.
$126
MACROGENICS, INC.
$125
Eisai Inc.
$121
JAZZ PHARMACEUTICALS INC.
$119
Pharmacosmos Therapeutics Inc.
$118
ARRAY BIOPHARMA INC
$115
Mirati Therapeutics, Inc.
$103
SOBI, INC
$99
GlaxoSmithKline, LLC.
$96
EMD Serono, Inc.
$83
Exelixis Inc.
$79
Clovis Oncology, Inc.
$62
Genmab U.S., Inc.
$61
MorphoSys, US Inc.
$59
AMAG Pharmaceuticals, Inc.
$57
SERVIER PHARMACEUTICALS LLC
$56
MEDIVATION FIELD SOLUTIONS LLC
$51
Stemline Therapeutics Inc.
$50
Agios Pharmaceuticals, Inc.
$49
Sun Pharmaceutical Industries Inc.
$47
Acrotech Biopharma Inc.
$46
G1 Therapeutics, Inc.
$46
EUSA Pharma (US) LLC
$45
Global Blood Therapeutics, Inc.
$44
CTI BioPharma Corp.
$41
Taiho Oncology, Inc.
$41
Sobi, Inc
$41
ADC Therapeutics America, Inc.
$39
Rigel Pharmaceuticals, Inc.
$39
TESARO, Inc.
$37
Janssen Pharmaceuticals, Inc
$36
West Therapeutics Development, LLC
$33
GT Medical Technologies, Inc
$31
Shire North American Group Inc
$28
Lexicon Pharmaceuticals, Inc.
$25
AbbVie Inc.
$23
AVEO Pharmaceuticals, Inc.
$21
Acrotech Biopharma LLC
$21
Blueprint Medicines Corporation
$21
Karyopharm Therapeutics Inc.
$21
CSL Behring
$20
SpringWorks Therapeutics, Inc.
$18
Alnylam Pharmaceuticals Inc.
$18
Dova Pharmaceuticals
$17
Dendreon Pharmaceuticals LLC
$16
TAIHO ONCOLOGY, INC.
$16
Aurobindo Pharma USA, Inc.
$15
PUMA BIOTECHNOLOGY, INC.
$14
Sysmex Inostics Inc
$14
Verastem, Inc.
$14
MAYNE PHARMA INC.
$14
Adaptive Biotechnologies Corporation
$13
Top 3 companies account for 29.6% of total payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Afstyla · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BLENREP · BOSULIF · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Epkinly · Erleada · FEMARA · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · Folotyn · GAMMATILE · GAZYVA · GILOTRIF · GIVLAARI · GammaTile · Gazyva · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idhifa · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ODOMZO (sonidegib) capsules · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROSTATE CANCER - DISEASE · PROVENGE · PYRUKYND · Padcev · Perjeta · Polivy · Pomalyst · Prolia · Quzyttir · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rubraca · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SUTENT · Somatuline Depot · Stivarga · Subsys · Sylvant · TASIGNA · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · Vanflyta · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Yescarta · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $18 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
8
Per 100K population
1.4
County median income
$66,581
Nearest hospital
ADVENTHEALTH DELAND
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bustinza Linares is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bustinza Linares experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Bustinza Linares performed 58,650 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bustinza Linares receive payments from pharmaceutical companies?
Yes. Dr. Bustinza Linares received a total of $18,795 from 85 companies across 989 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bustinza Linares's costs compare to other hematologys in Deland?
Dr. Bustinza Linares's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bustinza Linares) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Deland
Browse hematologys in Deland ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology